Levilimab
Modify Date: 2024-04-05 14:57:52
Levilimab structure
|
Common Name | Levilimab | ||
|---|---|---|---|---|
| CAS Number | 2035008-70-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LevilimabLevilimab (BCD-089) is a fully human anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid[1]. |
| Name | Levilimab |
|---|
| Description | Levilimab (BCD-089) is a fully human anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |